Rare Classroom: Acromegaly
source: shutterstock

Rare Classroom: Acromegaly

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Acromegaly
Oral Octreotide Approved to Treat Acromegaly
source: pixabay.com

Oral Octreotide Approved to Treat Acromegaly

As shared in Medscape, the FDA recently approved oral octreotide (Mycapssa) for the treatment of patients with acromegaly. These delayed-release capsules are the first approved oral somatostatin analog ever approved.…

Continue Reading Oral Octreotide Approved to Treat Acromegaly
Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
source: pixabay.com

Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA

On April 28th, 2020, Acromegaly Community, a nonprofit organization that is dedicated to supporting acromegaly patients, will be hosting a patient focused drug development meeting (PFDD). These meetings are an…

Continue Reading Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA